Related references
Note: Only part of the references are listed.Incidence and clinical implications of GATA1mutations in newborns with Down syndrome
Sharon R. Pine et al.
BLOOD (2007)
Novel RUNX1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD56 expression
Stefan Gattenloehner et al.
BLOOD (2007)
Janus kinase mutations in the development of acute megakaryoblastic leukemia in children with and without Down's syndrome
J. H. Klusmann et al.
LEUKEMIA (2007)
An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis
Luciana M. Hollanda et al.
NATURE GENETICS (2006)
A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481
Gita V. Massey et al.
BLOOD (2006)
Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling
JP Bourquin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia
YB Ge et al.
BLOOD (2006)
Acute megakaryoblastic leukemia in children and adolescents, excluding Down's syndrome: improved outcome with intensified induction treatment
D Reinhardt et al.
LEUKEMIA (2005)
AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity
U Creutzig et al.
LEUKEMIA (2005)
Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1
Z Li et al.
NATURE GENETICS (2005)
Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts
C Langebrake et al.
KLINISCHE PADIATRIE (2005)
Life-threatening complications of transient abnormal myelopoiesis in neonates with Down syndrome
S Dormann et al.
EUROPEAN JOURNAL OF PEDIATRICS (2004)
Multiple sequence alignment with the Clustal series of programs
R Chenna et al.
NUCLEIC ACIDS RESEARCH (2003)
Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis
G Mundschau et al.
BLOOD (2003)
Fetal and neonatal leukemia
H Isaacs
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2003)
Transient leukaemia - A benign form of leukaemia in newborn infants with trisomy 21
A Zipursky
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome
J Wechsler et al.
NATURE GENETICS (2002)
Incidence and treatment of potentially lethal diseases in transient leukemia of Down syndrome: Pediatric oncology group study
F Al-Kasim et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2002)
Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome
CM Zwaan et al.
BLOOD (2002)
Generation of definitive hematopoietic stem cells from murine early yolk sac and paraaortic splanchnopleures by aorta-gonad-mesonephros region-derived stromal cells
S Matsuoka et al.
BLOOD (2001)
Pattern of malignant disorders in individuals with Down's syndrome
Henrik Hasle
LANCET ONCOLOGY (2001)
Down's syndrome: The effects of prenatal diagnosis and demographic factors in a region of the eastern part of Germany
C Rosch et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2000)
Share Paper
